Form 4: Aspira Women's Health Director Acquires Shares and Warrants

Director Winfred Parnell acquired 3,268 shares of Aspira Women's Health Inc. along with warrants to purchase an additional 3,268 shares.

Summary

• On July 9, 2024, Winfred Parnell, a director of Aspira Women's Health Inc., acquired 3,268 shares of common stock.
• The acquisition also included 3,268 warrants, each allowing the purchase of one share of common stock at an exercise price of $2.25.
• The shares and warrants were purchased together at a price of $1.53 per share.
• Following the transaction, Parnell directly owns 34,781 shares of Aspira Women's Health Inc. and 3,268 warrants.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director purchasing shares and warrants suggests confidence, but the scale of the purchase is relatively small.

Positives

• A director's purchase of company stock and warrants can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are routine disclosures required by the SEC when company insiders, such as directors and officers, trade in their company's securities. These filings provide transparency into insider transactions and can be monitored by investors for insights into management's perspective on the company's value and prospects.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment.

Key Dates

Keywords

Aspira Women's Health, Director, Share Acquisition, Warrants, Form 4, Beneficial Ownership